TLR-mediated Immune Responses in the Urinary Tract

Overview

Journal Curr Opin Microbiol

Specialty Microbiology

Date 2008 Feb 5

PMID 18243043

Citations 42

Authors

Jeongmin Song

Soman N Abraham

Affiliations

Soon will be listed here.

Abstract

The urinary tract is one of the most intractable mucosal surfaces for pathogens to colonize. In addition to the natural barriers at this site, potential pathogens have to contend with the vigorous local innate immune system. Several Toll-like receptors (TLRs) have been identified on epithelial cells of the bladder and the kidneys which mediate a variety of powerful immune responses. A common finding among successful uropathogens is their intrinsic ability to suppress TLR-mediated responses. As antibiotic therapy becomes increasingly ineffective, employing boosters of the innate immune system in the urinary tract may become a viable option.

Citing Articles

A Dynamic Interplay of Innate Immune Responses During Urinary Tract Infection.

Naskar M, Choi H Immune Netw. 2024; 24(4):e31.

PMID: 39246616 PMC: 11377947. DOI: 10.4110/in.2024.24.e31.

DNA gene-dosage regulates the kidney innate immune response during upper urinary tract infection.

Canas J, Arregui S, Zhang S, Knox T, Calvert C, Saxena V Life Sci Alliance. 2024; 7(6).

PMID: 38580392 PMC: 10997819. DOI: 10.26508/lsa.202302462.

Lower Urinary Tract Inflammation and Infection: Key Microbiological and Immunological Aspects.

Dickson K, Zhou J, Lehmann C J Clin Med. 2024; 13(2).

PMID: 38256450 PMC: 10816374. DOI: 10.3390/jcm13020315.

Immune defenses in the urinary tract.

Kuhn H, Hreha T, Hunstad D Trends Immunol. 2023; 44(9):701-711.

PMID: 37591712 PMC: 10528756. DOI: 10.1016/j.it.2023.07.001.

Toll-like Receptor 9 Induced Dendritic Cell Activation Promotes Anti-Myeloperoxidase Autoimmunity and Glomerulonephritis.

Ford S, OSullivan K, Kitching A, Holdsworth S, Gan P, Summers S Int J Mol Sci. 2023; 24(2).

PMID: 36674855 PMC: 9864438. DOI: 10.3390/ijms24021339.

References

Chassin C, Goujon J, Darche S, du Merle L, Bens M, Cluzeaud F . Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways. J Immunol. 2006; 177(7):4773-84. DOI: 10.4049/jimmunol.177.7.4773. View

Andersen-Nissen E, Hawn T, Smith K, Nachman A, Lampano A, Uematsu S . Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol. 2007; 178(8):4717-20. DOI: 10.4049/jimmunol.178.8.4717. View

Schilling J, Mulvey M, Vincent C, Lorenz R, Hultgren S . Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol. 2001; 166(2):1148-55. DOI: 10.4049/jimmunol.166.2.1148. View

Hunstad D, Justice S, Hung C, Lauer S, Hultgren S . Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun. 2005; 73(7):3999-4006. PMC: 1168571. DOI: 10.1128/IAI.73.7.3999-4006.2005. View

Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, Karpman D . Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol. 2006; 9(1):33-9. DOI: 10.1016/j.mib.2005.12.012. View

Song J, Bishop B, Li G, Duncan M, Abraham S . TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe. 2007; 1(4):287-98. PMC: 1950120. DOI: 10.1016/j.chom.2007.05.007. View

Svanborg C, Godaly G . Bacterial virulence in urinary tract infection. Infect Dis Clin North Am. 1997; 11(3):513-29. DOI: 10.1016/s0891-5520(05)70371-8. View

Anderson G, Palermo J, Schilling J, Roth R, Heuser J, Hultgren S . Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003; 301(5629):105-7. DOI: 10.1126/science.1084550. View

Ragnarsdottir B, Samuelsson M, Gustafsson M, Leijonhufvud I, Karpman D, Svanborg C . Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis. 2007; 196(3):475-84. DOI: 10.1086/518893. View

10.

Hagberg L, Hull R, Hull S, McGhee J, Michalek S, Svanborg Eden C . Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun. 1984; 46(3):839-44. PMC: 261623. DOI: 10.1128/iai.46.3.839-844.1984. View

11.

Zhang D, Zhang G, Hayden M, Greenblatt M, Bussey C, Flavell R . A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303(5663):1522-6. DOI: 10.1126/science.1094351. View

12.

Justice S, Hung C, Theriot J, Fletcher D, Anderson G, Footer M . Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A. 2004; 101(5):1333-8. PMC: 337053. DOI: 10.1073/pnas.0308125100. View

13.

Shahin R, Engberg I, Hagberg L, Svanborg Eden C . Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol. 1987; 138(10):3475-80. View

14.

Justice S, Hunstad D, Harper J, Duguay A, Pinkner J, Bann J . Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J Bacteriol. 2005; 187(22):7680-6. PMC: 1280321. DOI: 10.1128/JB.187.22.7680-7686.2005. View

15.

Hooton T, Stamm W . Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997; 11(3):551-81. DOI: 10.1016/s0891-5520(05)70373-1. View

16.

Zhou G, Mo W, Sebbel P, Min G, Neubert T, Glockshuber R . Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci. 2001; 114(Pt 22):4095-103. DOI: 10.1242/jcs.114.22.4095. View

17.

Eto D, Jones T, Sundsbak J, Mulvey M . Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 2007; 3(7):e100. PMC: 1914067. DOI: 10.1371/journal.ppat.0030100. View

18.

Apodaca G . The uroepithelium: not just a passive barrier. Traffic. 2004; 5(3):117-28. DOI: 10.1046/j.1600-0854.2003.00156.x. View

19.

Lane M, Simms A, Mobley H . complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol. 2007; 189(15):5523-33. PMC: 1951814. DOI: 10.1128/JB.00434-07. View

20.

Bishop B, Duncan M, Song J, Li G, Zaas D, Abraham S . Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med. 2007; 13(5):625-30. DOI: 10.1038/nm1572. View